{
  "retracted": false,
  "timestamp": 1551916800000,
  "updates": [
    {
      "timestamp": 1587474715404,
      "identifier": {
        "doi": "10.1038/s41375-019-0426-8"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1038/s41375-018-0265-z"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia"
}
